Florida Financial Advisors LLC Raises Position in Cardinal Health, Inc. $CAH

Florida Financial Advisors LLC grew its position in Cardinal Health, Inc. (NYSE:CAH) by 25.7% in the 4th quarter, Holdings Channel reports. The institutional investor owned 12,560 shares of the company’s stock after purchasing an additional 2,571 shares during the quarter. Florida Financial Advisors LLC’s holdings in Cardinal Health were worth $2,575,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Vanguard Group Inc. raised its holdings in Cardinal Health by 2.0% in the fourth quarter. Vanguard Group Inc. now owns 31,441,258 shares of the company’s stock worth $6,461,179,000 after buying an additional 617,775 shares during the last quarter. Geode Capital Management LLC grew its stake in shares of Cardinal Health by 0.7% in the fourth quarter. Geode Capital Management LLC now owns 6,529,013 shares of the company’s stock worth $1,336,750,000 after acquiring an additional 43,924 shares during the period. Wellington Management Group LLP grew its stake in shares of Cardinal Health by 153.2% in the third quarter. Wellington Management Group LLP now owns 5,804,090 shares of the company’s stock worth $911,010,000 after acquiring an additional 3,511,579 shares during the period. Norges Bank bought a new stake in shares of Cardinal Health in the fourth quarter worth approximately $790,344,000. Finally, Bank of America Corp DE grew its stake in shares of Cardinal Health by 3.2% in the third quarter. Bank of America Corp DE now owns 3,592,775 shares of the company’s stock worth $563,922,000 after acquiring an additional 111,582 shares during the period. 87.17% of the stock is owned by hedge funds and other institutional investors.

Cardinal Health Trading Down 0.1%

Shares of NYSE CAH opened at $196.57 on Monday. The firm has a 50 day moving average of $203.52 and a 200 day moving average of $208.81. The firm has a market capitalization of $46.04 billion, a price-to-earnings ratio of 30.06, a price-to-earnings-growth ratio of 1.17 and a beta of 0.52. Cardinal Health, Inc. has a 12-month low of $137.75 and a 12-month high of $233.60.

Cardinal Health (NYSE:CAH) last announced its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.79 by $0.38. The company had revenue of $60.94 billion during the quarter, compared to analyst estimates of $62.10 billion. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. During the same period in the previous year, the business posted $2.35 earnings per share. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. Sell-side analysts predict that Cardinal Health, Inc. will post 10.76 EPS for the current year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Investors of record on Wednesday, July 1st will be given a dividend of $0.5158 per share. This represents a $2.06 annualized dividend and a yield of 1.0%. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. The ex-dividend date is Wednesday, July 1st. Cardinal Health’s dividend payout ratio (DPR) is presently 31.19%.

Analyst Ratings Changes

CAH has been the subject of a number of research analyst reports. Citigroup reduced their price target on shares of Cardinal Health from $249.00 to $245.00 and set a “buy” rating for the company in a research note on Friday, May 1st. TD Cowen lifted their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Mizuho lifted their price target on shares of Cardinal Health from $222.00 to $235.00 and gave the stock an “outperform” rating in a research note on Friday, February 6th. William Blair initiated coverage on shares of Cardinal Health in a research note on Tuesday, April 28th. They issued an “outperform” rating for the company. Finally, Wall Street Zen lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Saturday. One equities research analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.